2025
- Switching Roles─Exploring Concentration-Dependent Agonistic versus Antagonistic Behavior of Integrin Ligands. Journal of Medicinal Chemistry 68 (4), 2025, 4334-4351 more…
2024
- A UV-Vis method for investigation of gallium(<scp>iii</scp>) complexation kinetics with NOTA and TRAP chelators: advantages, limitations and comparison with radiolabelling. Dalton Transactions 53 (43), 2024, 17554-17564 more…
- PARP1-targeted fluorescence molecular endoscopy as novel tool for early detection of esophageal dysplasia and adenocarcinoma. Journal of Experimental & Clinical Cancer Research 43 (1), 2024 more…
- Isopeptidic Desferrioxamine Analogues: The Role of Hydroxamate Spacing for Chelation of Zr<sup>4+</sup>. ChemMedChem 20 (6), 2024 more…
- The importance of tyrosines in multimers of cyclic RGD nonapeptides: towards αvβ6-integrin targeted radiotherapeutics. RSC Medicinal Chemistry 15 (6), 2024, 2018-2029 more…
- Combining [177Lu]Lu-DOTA-TOC PRRT with PARP inhibitors to enhance treatment efficacy in small cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging 51 (13), 2024, 4099-4110 more…
- Three Is a Magic Number: Tailored Clickable Chelators Used to Determine Optimal RGD-Peptide Multiplicity in αvβ6-Integrin Targeted <sup>177</sup>Lu-Labeled Cancer Theranostics. Bioconjugate Chemistry 35 (12), 2024, 1970-1984 more…
- Efficiency of succinylated gelatin and amino acid infusions for kidney uptake reduction of radiolabeled αvβ6-integrin targeting peptides: considerations on clinical safety profiles. European Journal of Nuclear Medicine and Molecular Imaging 51 (11), 2024, 3191-3201 more…
2023
- Molecular View on the <i>i</i>RGD Peptide Binding Mechanism: Implications for Integrin Activity and Selectivity Profiles. Journal of Chemical Information and Modeling 63 (20), 2023, 6302-6315 more…
- Complexity of αvβ6-integrin targeting RGD peptide trimers: emergence of non-specific binding by synergistic interaction. RSC Medicinal Chemistry 14 (12), 2023, 2564-2573 more…
- Actionable loss of <scp>SLF2</scp> drives B‐cell lymphomagenesis and impairs the <scp>DNA</scp> damage response. EMBO Molecular Medicine 15 (9), 2023 more…